HCWB
HCW Biologics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.76M
P/E Ratio
—
EPS
$-9.71
Beta
1.14
52W High
$17.80
52W Low
$0.25
50-Day MA
$0.49
200-Day MA
$2.35
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About HCW Biologics Inc
HCW Biologics Inc is an innovative biotechnology company dedicated to developing cutting-edge immunotherapies and vaccine technologies for pressing health challenges such as cancer and infectious diseases. Leveraging proprietary platforms that harness the power of the immune system, HCW aims to deliver transformative biopharmaceutical solutions through its robust pipeline of clinical candidates. With strategic collaborations and a strong commitment to addressing unmet medical needs, HCW Biologics is poised for significant advancements in patient care, marking it as a compelling investment opportunity in the expanding biotechnology sector.
Fundamentals
| Revenue (TTM) | 54,230 |
| Gross Profit (TTM) | 10,850 |
| EBITDA | $-12.62M |
| Operating Margin | -18370.00% |
| Return on Equity | -27726.00% |
| Return on Assets | -31.20% |
| Revenue/Share (TTM) | $0.03 |
| Book Value | $0.84 |
| Price-to-Book | 1.10 |
| Price-to-Sales (TTM) | 50.94 |
| EV/Revenue | 145.68 |
| EV/EBITDA | -3.63 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -93.20% |
| Shares Outstanding | $6.73M |
| Float | $6.15M |
| % Insiders | 8.60% |
| % Institutions | 6.60% |
More HEALTHCARE Stocks
Data last updated: 5/5/2026